trial · primary record
VX-581
Cystic Fibrosis
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 16 |
| Primary completion | 2026-10-27 |
| Primary endpoint | Maximum Observed Plasma Concentration (Cmax) of VX-581 |
| Registry ID | NCT07813039 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:07.238Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07813039
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.